LY03003
LY03003 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro
A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients
A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
Clinical Trials (6)
A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro
A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients
A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6